| Randall C Boudreaux, MD | |
|
3719 Dauphin St, Springhill Anesthesia Department, Mobile, AL 36608-1753 | |
| (251) 342-3000 | |
| (251) 342-3043 |
| Full Name | Randall C Boudreaux |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 34 Years |
| Location | 3719 Dauphin St, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033182878 | NPI | - | NPPES |
| 000058779 | Medicaid | AL | |
| 105357 | Medicaid | AL | |
| CN0216 | Other | AL | MEDICARE TRAVELERS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 16510 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Usa Health University Hospital | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Anesthesia, P.c. | 1052213519 | 8 |
| Usa Health Anesthesia Billing Services Llc | 1153659123 | 136 |
News Archive
In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel investors, an increase of 121 percent over the amount raised by companies in 2009. The growth rate of dollars invested in regional companies is higher than recently released data from Thomson Reuters showing a 19 percent increase in dollars invested nationally.
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
Research shows how a new, more deadly strain of Salmonella emerged over an 18-month period. Becoming resistant to antibiotics, acquiring the ability to spread from person to person and losing genes along the way, the new strain has become a healthcare challenge in Africa, killing up to one in four patients.
Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center and an associate professor of medicine at Boston University School of Medicine, has received a $295,172 grant from the National Trauma Institute to identify optimal treatment methods for acute lung injury.
› Verified 8 days ago
| Entity Name | Coastal Anesthesia, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588637169 PECOS PAC ID: 1052213519 Enrollment ID: O20040123001037 |
News Archive
In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel investors, an increase of 121 percent over the amount raised by companies in 2009. The growth rate of dollars invested in regional companies is higher than recently released data from Thomson Reuters showing a 19 percent increase in dollars invested nationally.
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
Research shows how a new, more deadly strain of Salmonella emerged over an 18-month period. Becoming resistant to antibiotics, acquiring the ability to spread from person to person and losing genes along the way, the new strain has become a healthcare challenge in Africa, killing up to one in four patients.
Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center and an associate professor of medicine at Boston University School of Medicine, has received a $295,172 grant from the National Trauma Institute to identify optimal treatment methods for acute lung injury.
› Verified 8 days ago
| Entity Name | Providence Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952390643 PECOS PAC ID: 9830111871 Enrollment ID: O20051219000880 |
News Archive
In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel investors, an increase of 121 percent over the amount raised by companies in 2009. The growth rate of dollars invested in regional companies is higher than recently released data from Thomson Reuters showing a 19 percent increase in dollars invested nationally.
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
Research shows how a new, more deadly strain of Salmonella emerged over an 18-month period. Becoming resistant to antibiotics, acquiring the ability to spread from person to person and losing genes along the way, the new strain has become a healthcare challenge in Africa, killing up to one in four patients.
Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center and an associate professor of medicine at Boston University School of Medicine, has received a $295,172 grant from the National Trauma Institute to identify optimal treatment methods for acute lung injury.
› Verified 8 days ago
| Entity Name | Usa Health Anesthesia Billing Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629635818 PECOS PAC ID: 1153659123 Enrollment ID: O20190829000530 |
News Archive
In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel investors, an increase of 121 percent over the amount raised by companies in 2009. The growth rate of dollars invested in regional companies is higher than recently released data from Thomson Reuters showing a 19 percent increase in dollars invested nationally.
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
Research shows how a new, more deadly strain of Salmonella emerged over an 18-month period. Becoming resistant to antibiotics, acquiring the ability to spread from person to person and losing genes along the way, the new strain has become a healthcare challenge in Africa, killing up to one in four patients.
Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center and an associate professor of medicine at Boston University School of Medicine, has received a $295,172 grant from the National Trauma Institute to identify optimal treatment methods for acute lung injury.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randall C Boudreaux, MD Po Box 851417, Mobile, AL 36685-1417 Ph: (251) 342-3000 | Randall C Boudreaux, MD 3719 Dauphin St, Springhill Anesthesia Department, Mobile, AL 36608-1753 Ph: (251) 342-3000 |
News Archive
In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel investors, an increase of 121 percent over the amount raised by companies in 2009. The growth rate of dollars invested in regional companies is higher than recently released data from Thomson Reuters showing a 19 percent increase in dollars invested nationally.
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
Research shows how a new, more deadly strain of Salmonella emerged over an 18-month period. Becoming resistant to antibiotics, acquiring the ability to spread from person to person and losing genes along the way, the new strain has become a healthcare challenge in Africa, killing up to one in four patients.
Suresh Agarwal, MD, the chief of surgical critical care at Boston Medical Center and an associate professor of medicine at Boston University School of Medicine, has received a $295,172 grant from the National Trauma Institute to identify optimal treatment methods for acute lung injury.
› Verified 8 days ago
Dr. Alexandra Baxter Vanhaneghan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 51 Tacon St Ste D, Mobile, AL 36607 Phone: 205-934-4696 | |
Patricia K Mugnier, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 800-897-6169 Fax: 800-897-6170 | |
Travis Steven Steinke, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 51 Tacon St Ste D, Mobile, AL 36607 Phone: 251-341-2879 | |
Frances B Thurber, CRNA Anesthesiology Medicare: Medicare Enrolled Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-432-4497 Fax: 251-432-0577 | |
Dr. Jordan Christopher Friel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 51 Tacon St Ste D, Mobile, AL 36607 Phone: 251-341-2879 Fax: 251-316-3050 | |
Cassie Kennedy Burns, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3 Mobile Infirmary Cir Ste 410, Mobile, AL 36607 Phone: 251-435-6850 |